Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

Cancer Cell. 2005 Jun;7(6):575-89. doi: 10.1016/j.ccr.2005.05.007.

Abstract

Epidermal growth factor receptor (EGFR) exists in the nucleus of highly proliferative cells where it functions as a transcription factor. Although EGFR has transactivational activity, it lacks a DNA binding domain and, therefore, may require a DNA binding transcription cofactor for its transcriptional function. Here, we report that EGFR physically interacts with signal transducers and activators of transcription 3 (STAT3) in the nucleus, leading to transcriptional activation of inducible nitric oxide synthase (iNOS). In breast carcinomas, nuclear EGFR positively correlates with iNOS. This study describes a mode of transcriptional control involving cooperated efforts of STAT3 and nuclear EGFR. Our work suggests that the deregulated iNOS/NO pathway may partly contribute to the malignant biology of tumor cells with high levels of nuclear EGFR and STAT3.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Binding Sites / genetics
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • CHO Cells
  • Cell Line, Tumor
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism*
  • Cell Nucleus / ultrastructure
  • Cell Survival / drug effects
  • Chromatin Immunoprecipitation
  • Cricetinae
  • Cricetulus
  • DNA-Binding Proteins / metabolism*
  • Drug Synergism
  • Epidermal Growth Factor / pharmacology
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism*
  • Female
  • Gene Expression / drug effects
  • Gene Expression Regulation, Neoplastic
  • Genes, bcl-1 / genetics
  • Genes, fos / genetics
  • HeLa Cells
  • Humans
  • Janus Kinase 2
  • Microscopy, Fluorescence
  • Microscopy, Immunoelectron
  • Nitric Oxide / metabolism
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type II
  • Phosphorylation / drug effects
  • Prognosis
  • Promoter Regions, Genetic / genetics
  • Protein Binding / drug effects
  • Protein Kinase Inhibitors / pharmacology
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • STAT3 Transcription Factor
  • Signal Transduction / drug effects
  • Survival Analysis
  • Trans-Activators / metabolism*

Substances

  • DNA-Binding Proteins
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Trans-Activators
  • Nitric Oxide
  • Epidermal Growth Factor
  • S-Nitroso-N-Acetylpenicillamine
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2